Healthcare
Shuttle Pharmaceuticals Holdings, Inc.(SHPH)
Live Price
Offline$3.46
-20.82% today
1Y Change
-90.89%
Window
Jun 20, 2025 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- 0.0%
- EPS Growth
- +99.2%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 20, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a Healthcare stock with listed on NASDAQ. The stock last traded around $3.46 and down 90.9% across the available one-year price window (Jun 20, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +99.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +99.2%, free cash flow -29.4% with operating margin 0.0% and ROIC -460.8%. Stock Foundry combines SHPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +99.2%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -8.6% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 15, 2026 | โ | -6.9% | -12.6% | -43.5% |
2026 Apr 1, 2026 | โ | +12.8% | +7.7% | +53.0% |
2025 Nov 13, 2025 | โ | +0.4% | -20.8% | -22.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHPH
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SHPH Max Drawdown
-92.73%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SHPH and SPY.
Company Overview
Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ Global Market
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
- Leadership
- Christopher Robert Cooper
- IPO Date
- Aug 31, 2022
- Employees
- 9
- Street Address
- One Research Court
- Mailing
- Gaithersburg, MD, 20850
- Region
- Gaithersburg, MD, US
- Reporting Currency
- USD
- Investor Line
- 240 403 4212
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- 0.5
Growth
- Revenue
- 0.0%
- EPS
- +99.2%
- Free Cash Flow
- -29.4%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -444.9%
- ROIC
- -460.8%
Balance Sheet
- Debt/Equity
- 0.10
- Current Ratio
- 0.06
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.